363.48
1.09%
-4.98
전일 마감가:
$368.46
열려 있는:
$372.53
하루 거래량:
79,589
시가총액:
$26.84B
수익:
$2.93B
순이익/손실:
$568.70M
주가수익비율:
49.05
EPS:
7.41
순현금흐름:
$386.10M
1주 성능:
+1.11%
1개월 성능:
-5.87%
6개월 성능:
+8.79%
1년 성능:
-1.08%
West Pharmaceutical Services, Inc. Stock (WST) Company Profile
명칭
West Pharmaceutical Services, Inc.
전화
610-594-2900
주소
530 Herman O. West Drive, Exton, PA
West Pharmaceutical Services, Inc. Stock (WST) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
2022-12-14 | 개시 | Deutsche Bank | Hold |
2022-11-30 | 개시 | UBS | Neutral |
2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
2020-10-14 | 개시 | Stephens | Equal-Weight |
2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
2019-04-23 | 개시 | William Blair | Outperform |
2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
2018-01-24 | 개시 | Goldman | Neutral |
2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2017-10-03 | 개시 | Stephens | Equal-Weight |
2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
2016-03-22 | 개시 | Wells Fargo | Outperform |
2010-05-14 | 재확인 | UBS | Neutral |
2010-02-23 | 개시 | Jefferies & Co | Buy |
2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services, Inc. 주식(WST)의 최신 뉴스
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
Zacks Investment Research
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
Zacks Investment Research
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Zacks Investment Research
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
Zacks Investment Research
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
Zacks Investment Research
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
Zacks Investment Research
West Pharmaceutical Services, Inc. (WST) 재무 분석
West Pharmaceutical Services, Inc. (WST) 매출 2024
WST은 2024-03-31 종료 분기에 대해 매출(지난 12개월)이 2.93B 달러로 보고했으며, 전년대비 +1.56% 상승했습니다.
West Pharmaceutical Services, Inc. (WST) 순이익 2024
WST은 2024-03-31 종료 분기에 대해 순이익(지난 12개월)이 568.70M 달러로 보고했으며, 전년대비 +3.01% 증가했습니다.
West Pharmaceutical Services, Inc. (WST) 현금흐름 2024
2024-03-31 종료 분기에 WST은 현금흐름(지난 12개월)으로 386.10M 달러를 기록했으며, 전년 대비 -5.83% 감소했습니다.
West Pharmaceutical Services, Inc. (WST) 주당 순이익 2024
WST이 보고한 2024-03-31 종료 분기의 주당 순이익(지난 12개월)은 7.58달러이며, 전년 대비 +4.12% 성장했습니다.
West Pharmaceutical Services, Inc. 주식 (WST) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Winters Chad | VP, Chief Accounting Officer |
Mar 11 '24 |
Option Exercise |
173.22 |
675 |
116,924 |
2,124 |
Winters Chad | VP, Chief Accounting Officer |
Mar 11 '24 |
Sale |
358.82 |
815 |
292,436 |
1,309 |
Witherspoon Charles | VP & Treasurer |
Feb 28 '24 |
Option Exercise |
102.51 |
2,019 |
206,968 |
3,998 |
Witherspoon Charles | VP & Treasurer |
Feb 28 '24 |
Sale |
358.62 |
2,019 |
724,061 |
1,979 |
Green Eric Mark | President, CEO and Board Chair |
Feb 27 '24 |
Option Exercise |
57.38 |
73,132 |
4,196,314 |
217,040 |
Green Eric Mark | President, CEO and Board Chair |
Feb 27 '24 |
Sale |
359.85 |
64,132 |
23,077,971 |
152,908 |
Abraham Silji | SVP, Chief Technology Officer |
Feb 23 '24 |
Option Exercise |
173.22 |
7,012 |
1,214,619 |
11,672 |
Abraham Silji | SVP, Chief Technology Officer |
Feb 23 '24 |
Sale |
365.00 |
7,012 |
2,559,380 |
4,660 |
Winters Chad | VP, Chief Accounting Officer |
Dec 01 '23 |
Option Exercise |
156.18 |
797 |
124,472 |
2,283 |
Winters Chad | VP, Chief Accounting Officer |
Dec 01 '23 |
Sale |
349.00 |
1,013 |
353,541 |
1,270 |
자본화:
|
볼륨(24시간):